EMAS
 

Oncology

Oncology Prevalence of aromatase inhibitor-induced arthralgia in breast cancer: a systematic review and meta-analysis.
Beckwée D, Leysen L, Meuwis K, Adriaenssens N.
Support Care Cancer. 2017 Feb 15.
doi: 10.1007/s00520-017-3613-z. [Epub ahead of print] Review.
PMID: 28204994

learn more

Supplemental Selenium May Decrease Ovarian Cancer Risk in African-American Women.
Terry PD, Qin B, Camacho F, Moorman PG, Alberg AJ, Barnholtz-Sloan JS, Bondy M, Cote ML, Funkhouser E, Guertin KA, Peters ES, Schwartz AG, Schildkraut JM, Bandera EV.
J Nutr. 2017 Feb 15. pii: jn243279.
doi: 10.3945/jn.116.243279. [Epub ahead of print]
PMID: 28202637

learn more

Elevated Bone Turnover Markers after Risk-Reducing Salpingo-Oophorectomy in Women at Increased Risk for Breast and Ovarian Cancer.
Fakkert IE, van der Veer E, Abma EM, Lefrandt JD, Wolffenbuttel BH, Oosterwijk JC, Slart RH, Westrik IG, de Bock GH, Mourits MJ.
PLoS One. 2017 Jan 6;12(1):e0169673.
doi: 10.1371/journal.pone.0169673.
PMID: 28060958

learn more

Maternal exposure to ambient air pollution and risk of early childhood cancers: A population-based study in Ontario, Canada.
Lavigne É, Bélair MA, Do MT, Stieb DM, Hystad P, van Donkelaar A, Martin RV, Crouse DL, Crighton E, Chen H, Brook JR, Burnett RT, Weichenthal S, Villeneuve PJ, To T, Cakmak S, Johnson M, Yasseen AS 3rd, Johnson KC, Ofner M, Xie L, Walker M.
Environ Int. 2017 Jan 17. pii: S0160-4120(17)30046-6.
doi: 10.1016/j.envint.2017.01.004. [Epub ahead of print]
PMID: 28108116

learn more

Population Attributable Risk of Modifiable and Nonmodifiable Breast Cancer Risk Factors in Postmenopausal Breast Cancer.
Tamimi RM, Spiegelman D, Smith-Warner SA, Wang M, Pazaris M, Willett WC, Eliassen AH, Hunter DJ.
Am J Epidemiol. 2016 Dec 15;184(12):884-893.
PMID: 27923781

learn more

Physicians' Perspectives and Practice Patterns Toward Opportunistic Salpingectomy in High- and Low-Risk Women.
Jones NL, Schulkin J, Urban RR, Wright JD, Burke WM, Hou JY, McElwain CA, Tergas AI.
Cancer Invest. 2016 Dec 28:1-11. doi: 10.1080/07357907.2016.1242597. [Epub ahead of print]
PMID: 28029807

learn more

Cancer treatment and survivorship statistics, 2016.
Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH, Stein KD, Alteri R, Jemal A.
CA Cancer J Clin. 2016 Jul;66(4):271-89.
doi: 10.3322/caac.21349.
PMID: 27253694

learn more

Changing global policy to deliver safe, equitable, and affordable care for women's cancers.
Ginsburg O, Badwe R, Boyle P, Derricks G, Dare A, Evans T, Eniu A, Jimenez J, Kutluk T, Lopes G, Mohammed SI, Qiao YL, Rashid SF, Summers D, Sarfati D, Temmerman M, Trimble EL, Padela AI, Aggarwal A, Sullivan R.
Lancet. 2016 Nov 1. pii: S0140-6736(16)31393-9.
doi: 10.1016/S0140-6736(16)31393-9. [Epub ahead of print] Review.
PMID: 27814964

learn more

Reproductive and hormonal factors in relation to survival and platinum resistance among ovarian cancer cases.
Shafrir AL, Babic A, Tamimi RM, Rosner BA, Tworoger SS, Terry KL.
Br J Cancer. 2016 Oct 4. doi: 10.1038/bjc.2016.316.
PMID: 27701384

learn more

Health-related problems in adult cancer survivors: development and validation of the Cancer Survivor Core Set.
Geerse OP, Wynia K, Kruijer M, Schotsman MJ, Hiltermann TJ, Berendsen AJ.
Support Care Cancer. 2016 Oct 14.
PMID: 27743119

learn more

Breast cancer risk and protracted low-to-moderate dose occupational radiation exposure in the US Radiologic Technologists Cohort, 1983-2008.
Preston DL, Kitahara CM, Freedman DM, Sigurdson AJ, Simon SL, Little MP, Cahoon EK, Rajaraman P, Miller JS, Alexander BH, Doody MM, Linet MS.
Br J Cancer. 2016 Sep 13.
doi: 10.1038/bjc.2016.292. [Epub ahead of print]
PMID: 27623235

learn more

Psychological factors associated with the intention to choose for risk- reducing mastectomy in family cancer clinic attendees.
van Driel CM, Oosterwijk JC, Meijers-Heijboer EJ, van Asperen CJ, Zeijlmans van Emmichoven IA, de Vries J, Mourits MJ, Henneman L, Timmermans DR, de Bock GH.
Breast. 2016 Sep 14;30:66-72.
doi: 10.1016/j.breast.2016.08.016. [Epub ahead of print]
PMID: 27639031

learn more

Oncocardiology-Past, Present, and Future: A Review.
Yeh ET, Chang HM.
JAMA Cardiol. 2016 Aug 17. doi: 10.1001/jamacardio.2016.2132. [Epub ahead of print]
PMID: 27541948

learn more

The Potential of Radiomic-Based Phenotyping in Precision Medicine: A Review.
Aerts HJ.

JAMA Oncol. 2016 Aug 18. doi: 10.1001/jamaoncol.2016.2631. [Epub ahead of print]
PMID: 27541161

learn more

Endocrine Abnormalities in Aging Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study.
Mostoufi-Moab S, Seidel K, Leisenring WM, Armstrong GT, Oeffinger KC, Stovall M, Meacham LR, Green DM, Weathers R, Ginsberg JP, Robison LL, Sklar CA.
J Clin Oncol. 2016 Jul 5. pii: JCO666545. [Epub ahead of print]
PMID: 27382091

learn more

Exome genotyping arrays to identify rare and low frequency variants associated with epithelial ovarian cancer risk.
Permuth JB, Pirie A, Chen YA, et al; Ovarian Cancer Association Consortium.
Hum Mol Genet. 2016 Jul 4. pii: ddw196. [Epub ahead of print]
PMID: 27378695

learn more

Diet Quality and Colorectal Cancer Risk in the Women's Health Initiative Observational Study.
Vargas AJ, Neuhouser ML, George SM, Thomson CA, Ho GY, Rohan TE, Kato I, Nassir R, Hou L, Manson JE.
Am J Epidemiol. 2016 Jul 1;184(1):23-32. doi: 10.1093/aje/kwv304. Epub 2016 Jun 5.
PMID: 27267948

learn more

Carcinogenicity of drinking coffee, mate, and very hot beverages.
Loomis D, Guyton KZ, Grosse Y, Lauby-Secretan B, El Ghissassi F, Bouvard V, Benbrahim-Tallaa L, Guha N, Mattock H, Straif K; International Agency for Research on Cancer Monograph Working Group.
Lancet Oncol. 2016 Jun 14.
pii: S1470-2045(16)30239-X. doi: 10.1016/S1470-2045(16)30239-X. [Epub ahead of print]
PMID: 27318851

learn more

Reproductive factors and risk of luminal, HER2-overexpressing and triple negative breast cancer among multiethnic women.
Chen L, Li CI, Tang MC, Porter P, Hill DA, Wiggins CL, Cook LS.
Cancer Epidemiol Biomarkers Prev. 2016 Jun 15.
pii: cebp.1104.2015. [Epub ahead of print]
PMID: 27307466

learn more

Lifetime Number of Ovulatory Cycles and Risks of Ovarian and Endometrial Cancer Among Postmenopausal Women.
Yang HP, Murphy KR, Pfeiffer RM, George N, Garcia-Closas M, Lissowska J, Brinton LA, Wentzensen N.
Am J Epidemiol. 2016 May 1;183(9):800-14.
doi: 10.1093/aje/kwv308.
PMID: 27190045

learn more

Germline BRCA1/2 mutation testing is indicated in every patient with epithelial ovarian cancer: A systematic review.
Arts-de Jong M, de Bock GH, van Asperen CJ, Mourits MJ, de Hullu JA, Kets CM.
Eur J Cancer. 2016 May 17;61:137-145.
doi: 10.1016/j.ejca.2016.03.009. [Epub ahead of print] Review.
PMID: 27209246

learn more

Aspirin in the Treatment of Cancer: Reductions in Metastatic Spread and in Mortality: A Systematic Review and Meta-Analyses of Published Studies.
Elwood PC, Morgan G, Pickering JE, Galante J, Weightman AL, Morris D, Kelson M, Dolwani S.
PLoS One. 2016 Apr 20;11(4):e0152402.
doi: 10.1371/journal.pone.0152402. eCollection 2016.
PMID: 27096951

learn more

Diabetes mellitus type 2 and subsite-specific colorectal cancer risk in men and women: results from the Netherlands Cohort Study on diet and cancer.
de Kort S, Simons CC, van den Brandt PA, Goldbohm RA, Arts IC, de Bruine AP, Janssen-Heijnen ML, Sanduleanu S, Masclee AA, Weijenberg MP.
Eur J Gastroenterol Hepatol. 2016 Apr 19. [Epub ahead of print]
PMID: 27097356

learn more

Identifying predictors of delayed diagnoses in symptomatic breast cancer: a scoping review.
Webber C, Jiang L, Grunfeld E, Groome PA.
Eur J Cancer Care (Engl). 2016 Mar 7.
doi: 10.1111/ecc.12483. [Epub ahead of print]
PMID:26950652

learn more

Associations of body mass index with cancer incidence among populations, genders, and menopausal status: A systematic review and meta-analysis.
Wang J, Yang DL, Chen ZZ, Gou BF.
Cancer Epidemiol. 2016 Mar 3;42:1-8.
doi: 10.1016/j.canep.2016.02.010. [Epub ahead of print]
PMID: 26946037

learn more

Management of Differentiated Thyroid Cancer in Children: Focus on the American Thyroid Association Pediatric Guidelines.
Parisi MT, Eslamy H, Mankoff D.
Semin Nucl Med. 2016 Mar;46(2):147-164.
doi: 10.1053/j.semnuclmed.2015.10.006. Review.
PMID: 26897719

learn more

Cardiomyopathy Associated With Targeted Therapy for Breast Cancer.
Sivagnanam K, Rahman ZU, Paul T.
Am J Med Sci. 2016 Feb;351(2):194-199.
doi: 10.1016/j.amjms.2015.11.014.
PMID: 26897275

learn more

Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement.
Siu AL; U.S. Preventive Services Task Force.
Ann Intern Med. 2016 Jan 12.
doi: 10.7326/M15-2886. [Epub ahead of print]
PMID: 26757170

learn more

The Effect of the 2009 U.S. Preventive Services Task Force Breast Cancer Screening Recommendations on Mammography Rates.
Gray N, Picone G.
Health Serv Res. 2016 Jan 22.
doi: 10.1111/1475-6773.12445. [Epub ahead of print]
PMID: 26800299

learn more

Trajectory of body shape across the lifespan and cancer risk.
Song M, Willett WC, Hu FB, Spiegelman D, Must A, Wu K, Chan AT, Giovannucci EL.
Int J Cancer. 2015 Dec 24.
doi: 10.1002/ijc.29981. [Epub ahead of print]
PMID: 26704725

learn more

Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma.
Schaapveld M, Aleman BM, van Eggermond AM, Janus CP, Krol AD, van der Maazen RW, Roesink J, Raemaekers JM, de Boer JP, Zijlstra JM, van Imhoff GW, Petersen EJ, Poortmans PM, Beijert M, Lybeert ML, Mulder I, Visser O, Louwman MW, Krul IM, Lugtenburg PJ, van Leeuwen FE.
N Engl J Med. 2015 Dec 24;373(26):2499-511.
doi: 10.1056/NEJMoa1505949.
PMID: 26699166

learn more

Personalised and Precision Medicine in Cancer Clinical Trials: Panacea for Progress or Pandora's Box?
Lawler M, Sullivan R.
Public Health Genomics. 2015 Nov 11. [Epub ahead of print]
PMID: 26555236

learn more

Neurocognitive and Patient-Reported Outcomes in Adult Survivors of Childhood Osteosarcoma.
Edelmann MN, Daryani VM, Bishop MW, Liu W, Brinkman TM, Stewart CF, Mulrooney DA, Kimberg C, Ness KK, Cheung YT, Srivastava
DK, Robison LL, Hudson MM, Krull KR.
JAMA Oncol. 2015 Nov 19:1-8.
doi: 10.1001/jamaoncol.2015.4398. [Epub ahead of print]
PMID: 26583357

learn more

Dietary exposure to cadmium and risk of breast cancer in postmenopausal women: A systematic review and meta-analysis.
Van Maele-Fabry G, Lombaert N, Lison D.
Environ Int. 2015 Oct 16;86:1-13.
doi: 10.1016/j.envint.2015.10.003. [Epub ahead of print] Review.
PMID: 26479829

learn more

Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer.
Bowtell DD, Böhm S, Ahmed AA, Aspuria PJ, Bast RC Jr, Beral V, Berek JS, Birrer MJ, Blagden S, Bookman MA, Brenton JD, Chiappinelli KB, Martins FC, Coukos G, Drapkin R, Edmondson R, Fotopoulou C, Gabra H, Galon J, Gourley C, Heong V, Huntsman DG, Iwanicki M, Karlan BY, Kaye A, Lengyel E, Levine DA, Lu KH, McNeish IA, Menon U, Narod SA, Nelson BH, Nephew KP, Pharoah P, Powell DJ Jr, Ramos P, Romero IL, Scott CL, Sood AK, Stronach EA, Balkwill FR.
Nat Rev Cancer. 2015 Oct 23;15(11):668-79.
doi: 10.1038/nrc4019.
PMID: 26493647

learn more

Outcomes of special histotypes of breast cancer after adjuvant endocrine therapy with letrozole or tamoxifen in the monotherapy cohort of the BIG 1-98 trial.
Munzone E, Giobbie-Hurder A, Gusterson BA, Mallon E, Viale G, Thürlimann B, Ejlertsen B, MacGrogan G, Bibeau F, Lelkaitis G, Price KN, Gelber RD, Coates AS, Goldhirsch A, Colleoni M; International Breast Cancer Study Group and the BIG 1-98 Collaborative Group.
Ann Oncol. 2015 Sep 19.
pii: mdv391. [Epub ahead of print]
PMID: 26387144

learn more

Breast cancer screening utilization and understanding of current guidelines among rural U.S. women with private insurance.
Peppercorn J, Houck K, Beri N, Villagra V, Wogu AF, Lyman GH, Wheeler SB.
Breast Cancer Res Treat. 2015 Sep 19. [Epub ahead of print]
PMID: 26386956

learn more


Zoledronic acid for treatment of osteopenia and osteoporosis in women with primary breast cancer undergoing adjuvant aromatase inhibitor therapy: a 5-year follow-up.
Majithia N, Atherton PJ, Lafky JM, Wagner-Johnston N, Olson J, Dakhil SR, Perez EA, Loprinzi CL, Hines SL.
Support Care Cancer. 2015 Aug 23. [Epub ahead of print]
PMID: 26298334

learn more

Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization.
Zhang B, Shu XO, Delahanty RJ, et al
J Natl Cancer Inst. 2015 Aug 20;107(11).
pii: djv219. doi: 10.1093/jnci/djv219. Print 2015 Nov.
PMID: 26296642

learn more

Female Hormonal Factors and the Risk of Endometrial Cancer in Lynch Syndrome.Dashti SG, Chau R, Ouakrim DA, Buchanan DD, Clendenning M, Young JP, Winship IM, Arnold J, Ahnen DJ, Haile RW, Casey G, Gallinger S, Thibodeau SN, Lindor NM, Le Marchand L, Newcomb PA, Potter JD, Baron JA, Hopper JL, Jenkins MA, Win AK.
JAMA. 2015 Jul 7;314(1):61-71.
doi: 10.1001/jama.2015.6789.
PMID: 26151267

learn more

Laparoscopic and robot-assisted hysterectomy for uterine cancer: a comparison of costs and complications.
Zakhari A, Czuzoj-Shulman N, Spence AR, Gotlieb WH, Abenhaim HA.
Am J Obstet Gynecol. 2015 Jul 15.
pii: S0002-9378(15)00720-6. doi: 10.1016/j.ajog.2015.07.004. [Epub ahead of print]
PMID: 26188114

learn more

Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials.
Bernhard J, Luo W, Ribi K, Colleoni M, Burstein HJ, Tondini C, Pinotti G, Spazzapan S, Ruhstaller T, Puglisi F, Pavesi L, Parmar V, Regan MM, Pagani O, Fleming GF, Francis PA, Price KN, Coates AS, Gelber RD, Goldhirsch A, Walley BA.
Lancet Oncol. 2015 Jun 16. pii: S1470-2045(15)00049-2. doi: 10.1016/S1470-2045(15)00049-2. [Epub ahead of print]
PMID: 26092816

learn more


Tumour spectrum in non-BRCA hereditary breast cancer families in Sweden.
Wendt C, Lindblom A, Arver B, von Wachenfeldt A, Margolin S.
Hered Cancer Clin Pract. 2015 Jun 16;13(1):15. doi: 10.1186/s13053-015-0036-z. eCollection 2015.
PMID: 26082817

learn more

Occupational exposure to solvents and risk of breast cancer.
Glass DC, Heyworth J, Thomson AK, Peters S, Saunders C, Fritschi L.
Am J Ind Med. 2015 May 26.
doi: 10.1002/ajim.22478. [Epub ahead of print]
PMID: 26010434

learn more

Self-reported memory problems in adult-onset cancer survivors: effects of cardiovascular disease and insomnia.
Jean-Pierre P, Grandner MA, Garland SN, Henry E, Jean-Louis G, Burish TG.
Sleep Med. 2015 Mar 18.
pii: S1389-9457(15)00643

learn more

Long-term exposure to air pollution and mammographic density in the Danish Diet, Cancer and Health cohort.
Huynh S, von Euler-Chelpin M, Raaschou-Nielsen O, Hertel O, Tjønneland A, Lynge E, Vejborg I, Andersen ZJ.
Environ Health. 2015 Apr 1;14(1):31.
doi: 10.1186/s12940-015-0017-8.
PMID: 25879829

learn more

Long-term hazard of recurrence in HER2+ breast cancer patients untreated with anti-HER2 therapy.
Strasser-Weippl K, Horick N, Smith IE, O'Shaughnessy J, Ejlertsen B, Boyle F, Buzdar AU, Fumoleau P, Gradishar W, Martin M, Moy B, Piccart-Gebhart M, Pritchard KI, Lindquist D, Rappold E, Finkelstein DM, Goss PE.
Breast Cancer Res. 2015 Apr 16;17(1):56. [Epub ahead of print]
PMID: 25888246

learn more

Menstrual and reproductive history and use of exogenous sex hormones and risk of thyroid cancer among women: a meta-analysis of prospective studies.
Caini S, Gibelli B, Palli D, Saieva C, Ruscica M, Gandini S.
Cancer Causes Control. 2015 Apr;26(4):511-8. Epub 2015 Mar 10.
doi: 10.1007/s10552-015-0546-z.
PMID: 25754110

learn more

An epidemiologic risk prediction model for ovarian cancer in Europe: the EPIC study.
Li K, Hüsing A, Fortner RT, Tjønneland A, Hansen L, et al.
Br J Cancer. 2015 Mar 5. [Epub ahead of print]
doi: 10.1038/bjc.2015.22.
PMID: 25742479

learn more

Risk factors for negative impacts on sexual activity and function in younger breast cancer survivors.
Lee M, Kim YH, Jeon MJ.
Psychooncology. 2015 Feb 17. [Epub ahead of print]
doi: 10.1002/pon.3772.
PMID: 25690696

learn more

Mammographic breast density and breast cancer risk: interactions of percent density, absolute dense, and non-dense areas with breast cancer risk factors.
Yaghjyan L, Colditz GA, Rosner B, Tamimi RM.
Breast Cancer Res Treat. 2015 Feb 13. [Epub ahead of print]
PMID: 25677739

learn more

Facilitating lifestyle changes to manage menopausal symptoms in women with breast cancer: a randomized controlled pilot trial of The Pink Women's Wellness Program.
Anderson DJ, Seib C, McCarthy AL, Yates P, Porter-Steele J, McGuire A, Young L.
Menopause. 2015 Jan 20. [Epub ahead of print]
PMID: 25608273

learn more

Stopping ovarian cancer screening in BRCA1/2 mutation carriers: Effects on risk management decisions & outcome of risk-reducing salpingo-oophorectomy specimens.
van Driel CM, de Bock GH, Arts HJ, Sie AS, Hollema H, Oosterwijk JC, Mourits MJ.
Maturitas. 2014 Dec 30. [Epub ahead of print]
pii: S0378-5122(14)00399-5.
doi: 10.1016/j.maturitas.2014.12.009.
PMID: 25600260

learn more

Which benefits and harms of preoperative radiotherapy should be addressed? A Delphi consensus study among rectal cancer patients and radiation oncologists.
Kunneman M, Pieterse AH, Stiggelbout AM, Marijnen CA.
Radiother Oncol. 2014 Dec 11. [Epub ahead of print]
pii: S0167-8140(14)00539-8. doi: 10.1016/j.radonc.2014.11.034.
PMID: 25497119

learn more

A Genome Wide Meta-Analysis Study for Identification of Common Variation Associated with Breast Cancer Prognosis.
Rafiq S, Khan S, Tapper W, Collins A, Upstill-Goddard R, Gerty S, Blomqvist C, Aittomäki K, Couch FJ, Liu J, Nevanlinna H, Eccles D.
PLoS One. 2014 Dec 19;9(12):e101488. doi: 10.1371/journal.pone.0101488. eCollection 2014.
PMID: 25526632

learn more

Hormone therapy after uterine cervical cancer treatment: a Swedish population-based study.
Everhov AH, Nyberg T, Bergmark K, Citarella A, Rådestad AF, Hirschberg AL, Smedby KE.
Menopause. 2014 Nov 17. [Epub ahead of print]
PMID: 25405572

learn more

International Federation of Gynecology and Obstetrics Staging Classification for Cancer of the Ovary, Fallopian Tube, and Peritoneum: Estimation of Survival in Patients With Node-Positive Epithelial Ovarian Cancer.
Pereira A, Pérez-Medina T, Magrina JF, Magtibay PM, Rodríguez-Tapia A, Peregrin I, Mendizabal E, Ortiz-Quintana L.
Int J Gynecol Cancer. 2014 Nov 15. [Epub ahead of print]
PMID: 25405578

learn more

Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study.
Van Calster B, Van Hoorde K, Valentin L, Testa AC, Fischerova D, Van Holsbeke C, Savelli L, Franchi D, Epstein E, Kaijser J, Van Belle V, Czekierdowski A, Guerriero S, Fruscio R, Lanzani C, Scala F, Bourne T, Timmerman D; International Ovarian Tumour Analysis (IOTA) group.
BMJ. 2014 Oct 15;349:g5920.
doi: 10.1136/bmj.g5920.
PMID: 25320247

learn more

Racial differences in breast cancer, cardiovascular disease, and all-cause mortality among women with ductal carcinoma in situ of the breast.
Berkman A, F Cole B, Ades PA, Dickey S, Higgins ST, Trentham-Dietz A, Sprague BL, Lakoski SG.
Breast Cancer Res Treat. 2014 Oct 18. [Epub ahead of print]
PMID: 25326349

learn more

Drug withdrawal in women with progressive metastatic breast cancer while on aromatase inhibitor therapy.
Chavarri-Guerra Y, Higgins MJ, Szymonifka J, Cigler T, Liedke P, Partridge A, Ligibel J, Come SE, Finkelstein D, Ryan PD, Goss PE.
Br J Cancer. 2014 Sep 18. [Epub ahead of print]
doi: 10.1038/bjc.2014.502.
PMID: 25233398

learn more


Disparities in uptake of BRCA1/2 genetic testing in a randomized trial of telephone counseling.
Butrick M, Kelly S, Peshkin BN, Luta G, Nusbaum R, Hooker GW, Graves K, Feeley L, Isaacs C, Valdimarsdottir HB, Jandorf L, DeMarco T, Wood M, McKinnon W, Garber J, McCormick SR, Schwartz MD.
Genet Med. 2014 Sep 18. [Epub ahead of print]
doi: 10.1038/gim.2014.125.
PMID: 25232856

learn
more

Risk of Premature Menopause After Treatment for Hodgkin's Lymphoma.
Swerdlow AJ, Cooke R, Bates A, Cunningham D, Falk SJ, Gilson D, Hancock BW, Harris SJ, Horwich A, Hoskin PJ, Linch DC, Lister A, Lucraft HH, Radford J, Stevens AM, Syndikus I, Williams MV; England and Wales Hodgkin Lymphoma Follow-up Group*.
J Natl Cancer Inst. 2014 Aug 19;106(9).
pii: dju207. doi: 10.1093/jnci/dju207.
PMID: 25139687

learn more

Recent Recreational Physical Activity and Breast Cancer Risk in Postmenopausal Women in the E3N Cohort.
Fournier A, Dos Santos G, Guillas G, Bertsch J, Duclos M, Boutron-Ruault MC, Clavel-Chapelon F, Mesrine S.
Cancer Epidemiol Biomarkers Prev. 2014 Aug 11. [Epub ahead of print]
PMID:25114017

learn more

A Randomized Phase II Presurgical Trial of Transdermal 4-Hydroxytamoxifen Gel versus Oral Tamoxifen in Women with Ductal Carcinoma In Situ of the Breast.
Lee O, Page K, Ivancic D, Helenowski I, Parini V, Sullivan ME, Margenthaler JA, Chatterton RT Jr, Jovanovic B, Dunn BK, Heckman-Stoddard BM, Foster K, Muzzio M, Shklovskaya J, Skripkauskas S, Kulesza P, Green D, Hansen NM, Bethke KP, Jeruss JS, Bergan R, Khan SA.
Clin Cancer Res. 2014 Jul 15;20(14):3672-82.
doi: 10.1158/1078-0432.CCR-13-3045.
PMID: 25028506

learn more

Screening pelvic examinations in asymptomatic, average-risk adult women: an evidence report for a clinical practice guideline from the american college of physicians.
Bloomfield HE, Olson A, Greer N, Cantor A, MacDonald R, Rutks I, Wilt TJ.
Ann Intern Med. 2014 Jul 1;161(1):46-53.
doi: 10.7326/M13-2881.
PMID: 24979449

learn more

Combination treatment of tamoxifen with risperidone in breast cancer.
Yeh WL, Lin HY, Wu HM, Chen DR.
PLoS One. 2014 Jun 2;9(6):e98805.
doi: 10.1371/journal.pone.0098805. eCollection 2014.
PMID: 24886861

learn more


Dietary protein sources in early adulthood and breast cancer incidence: prospective cohort study.
Farvid MS ,Cho E ,Chen WY ,Eliassen AH ,Willett WC.
BMJ. 2014 Jun 10;348:g3437.
doi: 10.1136/bmj.g3437.
PMID: 24916719

learn more

The effect of information about overdetection of breast cancer on women's decision-making about mammography screening: study protocol for a randomised controlled trial.
Hersch J, Barratt A, Jansen J, Houssami N, Irwig L, Jacklyn G, Dhillon H, Thornton H, McGeechan K, Howard K, McCaffery K.

BMJ Open. 2014 May 15;4(5):e004990.
doi: 10.1136/bmjopen-2014-004990.
PMID: 24833692
learn more

Second primary cancers in survivors of cervical cancer in the Netherlands: Implications for prevention and surveillance.
Arnold M, Liu L, Kenter GG, Creutzberg CL, Coebergh JW, Soerjomataram I.
Radiother Oncol. 2014 May 12. [Epub ahead of print]
pii: S0167-8140(14)00174-1. doi: 10.1016/j.radonc.2014.04.011.
PMID: 24833558

learn more

Effect of statin on risk of gynecologic cancers: A meta-analysis of observational studies and randomized controlled trials.
Liu Y, Qin A, Li T, Qin X, Li S.
Gynecol Oncol. 2014 Apr 12. [Epub ahead of print]
pii: S0090-8258(14)00864-6. doi: 10.1016/j.ygyno.2014.04.007.
PMID: 24736024

learn more

Circulating adiponectin and breast cancer risk: a systematic review and meta-analysis.
Macis D, Guerrieri-Gonzaga A, Gandini S.
Int J Epidemiol. 2014 Apr 15. [Epub ahead of print]
PMID: 24737805

learn more

Sweetened carbonated beverage consumption and cancer risk: meta-analysis and review.
Boyle P, Koechlin A, Autier P.
Eur J Cancer Prev. 2014 Mar 12. [Epub ahead of print]
PMID: 24625472

learn more

Review of current best practice and priorities for research in radiation oncology for elderly patients with cancer: the International Society of Geriatric Oncology (SIOG) task force.
Kunkler IH, Audisio R, Belkacemi Y, Betz M, Gore E, Hoffe S, Kirova Y, Koper P, Lagrange JL, Markouizou A, Pfeffer R, Villa S; On behalf of the SIOG Radiotherapy Task Force.
Ann Oncol. 2014 Mar 13. [Epub ahead of print]
PMID: 24625455

learn more

Predictive Factors and Patterns of Recurrence in Patients with Triple Negative Breast Cancer.
Steward L, Conant L, Gao F, Margenthaler JA.
Ann Surg Oncol. 2014 Feb 21. [Epub ahead of print]
PMID: 24558065

learn more

A chemoresponse assay for prediction of platinum resistance in primary ovarian cancer.
Krivak TC, Lele S, Richard S, Alvarez Secord A, Leath CA 3rd, Brower SL, Tian C, Moore RG.
Am J Obstet Gynecol. 2014 Feb 12. [Epub ahead of print]
pii: S0002-9378(14)00126-4. doi: 10.1016/j.ajog.2014.02.009.
PMID: 24530815

learn more

Interactions of hormone replacement therapy, body weight and bilateral oophorectomy in breast cancer risk.
Cui Y, Deming-Halverson S, Beeghly-Fadiel A, Lipworth L, Shrubsole MJ, Fair AM, Shu XO, Zheng W.
Clin Cancer Res. 2014 Jan 14. [Epub ahead of print]
PMID: 24423614

learn
more

Reproductive factors and risk of hormone receptor positive and negative breast cancer: a cohort study.
Ritte R, Tikk K, Lukanova A, Tjønneland A, Olsen A, Overvad K, Dossus L, Fournier A, Clavel-Chapelon F, Grote V, Boeing H, Aleksandrova K, Trichopoulou A, Lagiou P, Trichopoulos D, Palli D, Berrino F, Mattiello A, Tumino R, Sacerdote C, Quirós JR, Buckland G, Molina-Montes E, Chirlaque MD, Ardanaz E, Amiano P, Bueno-de-Mesquita HB, van Gils CH, Peeters PH, Wareham N, Khaw KT, Key TJ, Travis RC, Weiderpass E, Dumeaux V, Lund E, Sund M, Andersson A, Romieu I, Rinaldi S, Vineis P, Merritt MA, Riboli E, Kaaks R.
BMC Cancer. 2013 Dec 9;13(1):584.
PMID: 24321460

learn
more

Metformin decreases circulating androgen and estrogen levels in nondiabetic women with breast cancer.
Campagnoli C, Berrino F, Venturelli E, Abbà C, Biglia N, Brucato T, Cogliati P, Danese S, Donadio M, Zito G, Pasanisi P.
Clin Breast Cancer. 2013 Dec;13(6):433-8.
doi: 10.1016/j.clbc.2013.08.012.
PMID: 24267731

learn
more

Type 1 plasminogen activator inhibitor as a common risk factor for cancer and ischaemic vascular disease: the EPICOR study.
Iacoviello L, Agnoli C, De Curtis A, di Castelnuovo A, Giurdanella MC, Krogh V, Mattiello A, Matullo G, Sacerdote C, Tumino R, Vineis P, de Gaetano G, Panico S, Donati MB.
BMJ Open. 2013 Nov 14;3(11):e003725. doi: 10.1136/bmjopen-2013-003725.
PMID: 24231461

learn
more

Breast Cancer Risk in Opposite-Sexed Twins: Influence of Birth Weight and Co-Twin Birth Weight.
Hajiebrahimi M, Bahmanyar S, Oberg S, Iliadou AN, Cnattingius S.
J Natl Cancer Inst. 2013 Nov 14. [Epub ahead of print]
PMID: 24231452

learn
more

A case-control study of lifetime light intensity physical activity and breast cancer risk.
Kobayashi LC, Janssen I, Richardson H, Lai AS, Spinelli JJ, Aronson KJ.
Cancer Causes Control. 2013 Oct 25. [Epub ahead of print]
PMID: 24158779

learn
more

Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Ledermann JA, Raja FA, Fotopoulou C, Gonzalez-Martin A, Colombo N, Sessa C; ESMO Guidelines Working Group.
Ann Oncol. 2013 Oct;24 Suppl 6:vi24-vi32.
doi: 10.1093/annonc/mdt333.
PMID: 24078660

learn
more

Breast-Conserving Treatment With or Without Radiotherapy in Ductal Carcinoma In Situ: 15-Year Recurrence Rates and Outcome After a Recurrence, From the EORTC 10853 Randomized Phase III Trial.
Donker M, Litière S, Werutsky G, Julien JP, Fentiman IS, Agresti R, Rouanet P, de Lara CT, Bartelink H, Duez N, Rutgers EJ, Bijker N.
J Clin Oncol. 2013 Sep 16. [Epub ahead of print]
PMID: 24043739

learn
more

Intake of coffee, caffeine and other methylxanthines and risk of Type I vs Type II endometrial cancer.
Uccella S, Mariani A, Wang AH, Vierkant RA, Cliby WA, Robien K, Anderson KE, Cerhan JR.
Br J Cancer. 2013 Sep 10. [Epub ahead of print]
doi: 10.1038/bjc.2013.540.
PMID: 24022184

learn
more

Breast Cancer, Version 3.2013.
Guideline-Inconsistent Breast Cancer Screening for Women over 50: A Vignette-Based Survey.
Kadivar H, Goff BA, Phillips WR, Andrilla CH, Berg AO, Baldwin LM.
J Gen Intern Med. 2013 Aug 14. [Epub ahead of print]
PMID: 23943421
learn more

Multicenter, Randomized Controlled Trial of Yoga for Sleep Quality Among Cancer Survivors.
Mustian KM, Sprod LK, Janelsins M, Peppone LJ, Palesh OG, Chandwani K, Reddy PS, Melnik MK, Heckler C, Morrow GR.
J Clin Oncol. 2013 Aug 12. [Epub ahead of print]
PMID: 23940231

learn more

Breast Cancer, Version 3.2013.
Theriault RL, Carlson RW, Allred C, Anderson BO, Burstein HJ, Edge SB, Farrar WB, Forero A, Giordano SH, Goldstein LJ, Gradishar WJ, Hayes DF, Hudis CA, Isakoff SJ, Ljung BM, Mankoff DA, Marcom PK, Mayer IA, McCormick B, Pierce LJ, Reed EC, Schwartzberg LS, Smith ML, Soliman H, Somlo G, Ward JH, Wolff AC, Zellars R, Shead DA, Kumar R.
J Natl Compr Canc Netw. 2013 Jul 1;11(7):753-761.
PMID: 23847214

learn more

Incidence of port site hernias and/or dehiscence in robotic-assisted procedures in gynecologic oncology patients.
Boone JD, Fauci JM, Barr ES, Estes JM, Bevis KS.
Gynecol Oncol. 2013 Jul 8. doi:pii: S0090-8258(13)00915-3. 10.1016/j.ygyno.2013.06.041. [Epub ahead of print]
PMID: 23845692

learn more

Non-Sex Cord-Stromal Ovarian Tumors Frequently Produce and Secrete Estrogen in Postmenopausal Women: Impact on Bone Metabolism and Abnormal Endometrial Histology.
Matsumura S, Ohta T, Takahashi T, Yamazaki T, Takahashi K, Kurachi H.
J Clin Endocrinol Metab. 2013 Jun 18. [Epub ahead of print]
learn more

Mild obesity, physical activity, calorie intake, and the risks of cervical intraepithelial neoplasia and cervical cancer.
Lee JK, So KA, Piyathilake CJ, Kim MK.
PLoS One. 2013 Jun 12;8(6):e66555. doi: 10.1371/journal.pone.0066555. Print 2013.
PMID: 23776686
learn more

Prophylactic use of levonorgestrel-releasing intrauterine system in women with breast cancer treated with tamoxifen: a randomized controlled trial.

Wong AW, Chan SS, Yeo W, Yu MY, Tam WH.
Obstet Gynecol. 2013 May;121(5):943-50. doi: 10.1097/AOG.0b013e31828bf80c.
PMID: 23635729

learn
more

Risk factors associated with venous thromboembolism in 49,028 mastectomy patients.
Tran BH, Joanna Nguyen T, Hwang BH, Vidar EN, Davis GB, Chan LS, Woo K, Wong AK.
Breast. 2013 May 18. doi:pii: S0960-9776(13)00099-4. 10.1016/j.breast.2013.04.018. [Epub ahead of print]
PMID: 23692931

learn
more

International variation in physicians' attitudes towards prophylactic mastectomy - Comparison between France, Germany, the Netherlands and the United Kingdom.
Den Heijer M, van Asperen CJ, Harris H, Nippert I, Schmidtke J, Bouhnik AD, Julian-Reynier C, Evans DG, Tibben A.
Eur J Cancer. 2013 May 18. doi:pii: S0959-8049(13)00359-6. 10.1016/j.ejca.2013.04.025. [Epub ahead of print]
PMID: 23692813

learn
more

Survival Analysis of Endometrial Cancer Patients With Positive Lymph Nodes.
Brown AP, Gaffney DK, Dodson MK, Soisson AP, Belnap TW, Alleman K, Sause WT.
Int J Gynecol Cancer. 2013 Apr 18. [Epub ahead of print]
PMID: 23598890

learn
more

Multicenter Phase II Trial of Topotecan, Cisplatin and Bevacizumab for Recurrent or Persistent Cervical Cancer.
Zighelboim I, Wright JD, Gao F, Case AS, Massad LS, Mutch DG, Powell MA, Thaker PH, Eisenhauer EL, Cohn DE, Valea FA, Secord AA, Lippmann LT, Dehdashti F, Rader JS.
Gynecol Oncol. 2013 Apr 13. [Epub ahead of print]
doi:pii: S0090-8258(13)00229-1. 10.1016/j.ygyno.2013.04.009.
PMID: 23591400

learn
more

Risk of ischemic heart disease in women after radiotherapy for breast cancer.
Darby SC, Ewertz M, McGale P, Bennet AM, Blom-Goldman U, Brønnum D, Correa C, Cutter D, Gagliardi G, Gigante B, Jensen MB, Nisbet A, Peto R, Rahimi K, Taylor C, Hall P.
N Engl J Med. 2013 Mar 14;368(11):987-98.
doi: 10.1056/NEJMoa1209825.
PMID: 23484825

learn more

Frequency of Severe Valvular Disease Caused by Mediastinal Radiation Among Patients Undergoing Valve Surgery in a Community-Based, Regional Academic Medical Center.
Copeland KA, Hosmane VR, Jurkovitz C, Kolm P, Bowen J, Disabatino A, Banbury MK, Strasser JF, Weintraub WS, Doorey AJ.
Clin Cardiol. 2013 Mar 14. [Epub ahead of print]
doi: 10.1002/clc.22106.
PMID: 23495041

learn
more

In vivo and in vitro demonstration of herb-drug interference in human breast cancer cells treated with tamoxifen and trastuzumab.
Chen JL, Wang JY, Tsai YF, Lin YH, Tseng LM, Chang WC, King KL, Chen WS, Chiu JH, Shyr YM.
Menopause. 2013 Jan 21. [Epub ahead of print]
PubMed PMID: 23340260.
learn
more

Evaluation of chemotherapy response with serum squamous cell carcinoma antigen level in cervical cancer patients: a prospective cohort study.
Yin M, Hou Y, Zhang T, Cui C, Zhou X, Sun F, Li H, Li X, Zheng J, Chen X, Li C, Ning X, Li K, Lou G.
PLoS One. 2013;8(1):e54969. Epub 2013 Jan 22.
doi: 10.1371/journal.pone.0054969.
PubMed PMID: 23349993.
learn
more

Prophylactic Salpingectomy and Delayed Oophorectomy as an Alternative for BRCA Mutation Carriers.
Kwon JS, Tinker A, Pansegrau G, McAlpine J, Housty M, McCullum M, Gilks CB.
Obstet Gynecol. 2013 Jan;121(1):14-24.
PubMed PMID: 23232752.
learn
more

Obesity as a risk factor for triple-negative breast cancers: a systematic review and meta-analysis.
Pierobon M, Frankenfeld CL.

Breast Cancer Res Treat. 2013 Jan;137(1):307-14.
doi: 10.1007/s10549-012-2339-3.
PubMed PMID: 23179600.
learn
more

Discovery and preliminary confirmation of novel early detection biomarkers for triple-negative breast cancer using preclinical plasma
samples from the Women's Health Initiative observational study.

Li CI, Mirus JE, Zhang Y, Ramirez AB, Ladd JJ, Prentice RL, McIntosh MW, Hanash SM, Lampe PD.
Breast Cancer Res Treat. 2012 Aug 19. [Epub ahead of print] PubMed PMID: 22903690.
learn more

Cancer survival in Eastern and Western Germany after the fall of the iron curtain.
Jansen L, Gondos A, Eberle A, Emrich K, Holleczek B, Katalinic A, Brenner H; GEKID Cancer Survival Working Group. Eur J Epidemiol. 2012 Aug 22. [Epub ahead of print] PubMed PMID: 22911023.
learn more
EMAS

EMAS ADMINISTRATIVE OFFICE · c/o K.I.T. Group GmbH · Association & Conference Management · Kurfürstendamm 71 · D - 10709 Berlin
Tel: +49 (0)30 24603-0 · Fax: +49 (0)30 24603-310 · E-mail: info@emas-online.org · Internet: www.emas-online.org